Specific incorporation of cyclophilin A into HIV-1 virions
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Little is known about host factors necessary for retroviral virion assembly or uncoating. We have previously shown that the principal structural protein of the human immunodeficiency virus HIV-1, the Gag polyprotein, binds the cyclophilin peptidyl-prolyl isomerases; cyclophilins catalyse a rate-limiting step in protein folding and protect cells from heat shock. Here we demonstrate that cyclophilin A is specifically incorporated into HIV-1 virions but not into virions of other primate immunodeficiency viruses. A proline-rich region conserved in all HIV-1 Gag polyproteins is required for cyclophilin A binding and incorporation. Disruption of a single proline blocks the Gag-cyclophilin interaction in vitro, prevents cyclophilin A incorporation into virions, and inhibits HIV-1 replication. Our results indicate that the interaction of Gag with cyclophilin A is necessary for the formation of infectious HIV-1 virions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The CA-NTD contains six to seven alphahelices and in some viruses a flexible loop region implicated in binding of cellular host factors”
From Retrovirus maturation-an extraordinary structural transformation (2016) · cites this paper as [15]
Citations
Cites
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., & Martin, M. A. (1986) · Journal of Virology · doi:10.1128/jvi.59.2.284-291.1986 · Cited by 2,834
Human Retroviruses and Aids - 1999
Kuiken, C., & Foley, B. (1999) · doi:10.2172/1186019 · Cited by 952
Genome organization and transactivation of the human immunodeficiency virus type 2
Guyader, M., Emerman, M., Sonigo, P., Clavel, F., Montagnier, L., & Alizon, M. (1987) · Nature · doi:10.1038/326662a0 · Cited by 848
[71] Use of eukaryotic expression technology in the functional analysis of cloned genes
Cullen, B. R. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)52074-2 · Cited by 822
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B
Luban, J., Bossolt, K. L., Franke, E. K., Kalpana, G. V., & Goff, S. P. (1993) · Cell · doi:10.1016/0092-8674(93)90637-6 · Cited by 802
Self-citationInduction of AIDS in Rhesus Monkeys by Molecularly Cloned Simian Immunodeficiency Virus
Kestler, H., Kodama, T., Ringler, D., Marthas, M., Pedersen, N., Lackner, A., Regier, D., Sehgal, P., Daniel, M., King, N., et al. (1990) · Science · doi:10.1126/science.2160735 · Cited by 514
Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus
(1992) · Infectious Diseases Newsletter · doi:10.1016/0278-2316(92)90022-6 · Cited by 497
Friedman, J., & Weissman, I. (1991) · Cell · doi:10.1016/0092-8674(91)90123-g · Cited by 395
Paxton, W., Connor, R. I., & Landau, N. R. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7229-7237.1993 · Cited by 371
Research works printed but not linked: 1
- Field, J. et al. Molec cell. Biol. 8, 2159–2165 (1988). · doi:10.1128/mcb.8.5.2159 · Paper page
Cited by
Items 601–700 of 749
Toward rationally designed peptidyl-prolyl isomerase inhibitors
Germanas, J. P., Kim, K., & Dumas, J. (1997) · Advances in amino acid mimetics and peptidomimetics · doi:10.1016/s1874-5113(97)80010-x · Cited by 7
Nuclear pore passage of the HIV capsid is driven by its unusual surface amino acid composition
Fu, L., Cheng, S., Riedel, D., Kopecny, L., Schuh, M., & Görlich, D. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-025-01684-5 · Cited by 7
Tambini, R., FIOCCHI, R., Gavazzeni, G., Perani, V., Mamprin, F., Delvecchio, G., & Fracassetti, O. (1997) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(97)90011-4 · Cited by 4
Cyclophilin A Is Not Acetylated at Lysine-82 and Lysine-125 in Resting and Stimulated Platelets
Rosa, A., Butt, E., Hopper, C. P., Loroch, S., Bender, M., Schulze, H., Sickmann, A., Vorlová, S., Seizer, P., Heinzmann, D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031469 · Cited by 4
Hamilton, G. S., & Thomas, C. (2000) · Advances in medicinal chemistry · doi:10.1016/s1067-5698(00)80003-6 · Cited by 4
Oligopeptide cyclophilin inhibitors: A reassessment
Schümann, M., Jahreis, G., Kahlert, V., Lücke, C., & Fischer, G. S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.09.019 · Cited by 4
Optimization of Cyclophilin Inhibitors for Use in Antiviral Therapy
Peel, M. R., & Scribner, A. W. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849737814-00384 · Cited by 4
Goff, S. P. (2004) · Elsevier eBooks · doi:10.1016/b978-012764051-8/50006-8 · Cited by 7
Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV
Lin, K. W. (2011) · doi:10.1002/9780470929353.ch22 · Cited by 4
Gag–Pol Region Determines the Tropism of SIVagm for Human Cells
Shimano, R., Inubushi, R., Amano, K., Ogasawa, T., & Adachi, A. (1998) · Virus Genes · doi:10.1023/a:1007971620863 · Cited by 4
Capsid-dependent lentiviral restrictions
Twentyman, J., Emerman, M., & OhAinle, M. (2024) · Journal of Virology · doi:10.1128/jvi.00308-24 · Cited by 4
Systematic discovery of pro- and anti-HIV host factors in primary human CD4+ T cells
Rathore, U., Dugan, E. J., Thornton, H., Kumar, V. E., Dajani, R., Burdick, R. C., Young, J. M., Steinhart, Z., Lao, R., Delviks‐Frankenberry, K. A., et al. (2026) · Cell · doi:10.1016/j.cell.2026.03.046 · Cited by 6
DC-targeting lentivectors for cancer immunotherapy
Gea‐Mallorquí, E., & Rowland‐Jones, S. (2023) · Immunotherapy Advances · doi:10.1093/immadv/ltad023 · Cited by 4
Functional 20S Proteasomes in Retroviruses: Evidence in Favor
Va, M., Morozov, A. V., & Карпов, В. Л. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111710 · Cited by 3
Takeuchi, H. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.10.020 · Cited by 3
Tóth, F., Kádas, J., Mótyán, J. A., & Tőzsér, J. (2016) · FEBS Open Bio · doi:10.1002/2211-5463.12094 · Cited by 3
Kishimoto, N., Okano, R., Akita, A., Miura, S., Irie, A., Takamune, N., & Misumi, S. (2021) · Retrovirology · doi:10.1186/s12977-021-00574-0 · Cited by 4
HIV capsids: orchestrators of innate immune evasion, pathogenesis and pandemicity
Morling, K. L., ElGhazaly, M., Milne, R. S. B., & Towers, G. J. (2025) · Journal of General Virology · doi:10.1099/jgv.0.002057 · Cited by 8
Cellular Factors That Regulate Retrovirus Uncoating and Reverse Transcription
Goff, S. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811185-7.00002-9 · Cited by 3
1-(2,6-Dibenzyloxybenzoyl)-3-(9H-fluoren-9-yl)-urea: A novel cyclophilin A allosteric activator
Lv, M., Shi, T., Mao, X., Li, X., Chen, Y., Zhu, J., Ni, S., Shen, X., Jiang, H., Li, J., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.014 · Cited by 3
Computer-assisted anti-AIDS drug development: cyclophilin B against the HIV-1 subtype A V3 loop
Andrianov, A. M., & Anishchenko, I. V. (2010) · Health · doi:10.4236/health.2010.27100 · Cited by 3
Restriction of the felid lentiviruses by a synthetic feline TRIM5–CypA fusion
Dietrich, I., McEwan, W. A., Hosie, M. J., & Willett, B. J. (2011) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2011.06.017 · Cited by 8
Interactions of HIV-1 Proteins as Targets for Developing Anti-HIV-1 Peptides
Chandra, K., Maes, M., & Friedler, A. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.46 · Cited by 3
Molecular Biology of HIV: Implications for New Therapies
Greene, W. C., & Peterlin, B. M. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-2882-6.50007-1 · Cited by 6
Speelmon, E. C., Livingston‐Rosanoff, D., Desbien, A. L., Lee, J. Y. H., Wick, W. D., Hladik, F., & McElrath, M. J. (2008) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0256 · Cited by 3
ChemInform Abstract: Toward Rationally Designed Peptidyl‐prolyl Isomerase Inhibitors
Germanas, J. P., Kim, K., & Dumas, J. (1999) · ChemInform · doi:10.1002/chin.199908313 · Cited by 3
Khan, M. B., Jin, L., Miles, L. R., Bond, V. C., & Powell, M. D. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.3211-3216.2005 · Cited by 3
Governed by surface amino acid composition: HIV capsid passage through the NPC barrierPreprint
Fu, L., Cheng, S., Riedel, D., Kopecny, L., Schuh, M., & Görlich, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.13.643050 · Cited by 3
Host Genetics and Resistance to HIV-1 Infection
Luo, M., McLaren, P. J., & Plummer, F. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-387715-4.00006-x · Cited by 2
Kameoka, M., Isarangkura-na-ayuthaya, P., Kameoka, Y., Sapsutthipas, S., Soonthornsata, B., Nakamura, S., Tokunaga, K., Sawanpanyalert, P., Ikuta, K., & Auwanit, W. (2010) · Virology · doi:10.1016/j.virol.2010.06.003 · Cited by 2
Cloning and characterization of peptidylprolyl isomerase B in the silkworm, Bombyx mori
Xia, H., Lv, H., Chen, K., Yao, Q., Lv, P., Li, J., Chen, H., & Wang, L. (2009) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.4314/ajb.v8i24.68806 · Cited by 2
Human Immunodeficiency Virus Grown in CD4-Expressing Cells is Associated with CD4
Hartley, C. A., Gilbert, M. J., Brígido, L. F. D. M., Elbeik, T., Levy, J., Crowe, S. M., & MILLS, J. S. (1996) · Journal of General Virology · doi:10.1099/0022-1317-77-9-2015 · Cited by 3
Molecular mechanisms of HIV-1 genetic diversity
Сосин, Д. В., & Tchurikov, N. A. (2017) · Molecular Biology · doi:10.1134/s0026893317030153 · Cited by 3
Human Mannose Receptor 1 Attenuates HIV-1 Infectivity in a Virus Isolate-Specific Manner
Saito, H., Sukegawa, S., Kao, S., & Strebel, K. (2023) · Viruses · doi:10.3390/v15102057 · Cited by 3
Human Immunodeficiency Virus From Virus Structure to Pathogenesis
Gelderblom, H. R., & Böller, K. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47650-9_11 · Cited by 2
Catalysis of Peptidyl‐prolylcis/transIsomerization by Enzymes
Fischer, G. (2005) · doi:10.1002/9783527619498.ch43 · Cited by 2
IMMUNOBIOLOGY OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
Tripathi, P., & Agrawal, S. (2007) · Indian Journal of Medical Microbiology · doi:10.1016/s0255-0857(21)02044-2 · Cited by 11
Ratner, L. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0191-0_1 · Cited by 1
TRIM5α/Cyclophilin A-Modified MDBK Cells for Lentiviral-Based Gene Editing
Wo, L., Qi, S., Guo, Y., Sun, C., & Yin, X. (2025) · Viruses · doi:10.3390/v17070876 · Cited by 1
Verathamjamras, C. (2015) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000218 · Cited by 1
From Cell Surface to the Nucleus, a Short but Critical Journey for Retroviruses
Renault, N., & Saïb, A. (2006) · Future Virology · doi:10.2217/17460794.1.3.331 · Cited by 1
Comparative genetic variability in HIV-1 subtype C p24 Gene in early age groups of infants
Sharma, U., Gupta, S., Venkatesh, S., Rai, A., Dhariwal, A. C., & Husain, M. (2018) · Virus Genes · doi:10.1007/s11262-018-1588-6 · Cited by 1
Aiken, C. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0638-8 · Cited by 1
Phospholipase A 2 Activates Hemostasis
Stief, T. W. (2007) · Drug Target Insights · doi:10.33393/dti.2007.1317 · Cited by 12
Exploration of the Role of Cyclophilins in Established Hepatitis B and C Infections
Molle, J., Duponchel, S., Rieusset, J., Ovize, M., Ivanov, A. V., Zoulim, F., & Bartosch, B. (2024) · Viruses · doi:10.3390/v17010011 · Cited by 1
МОЛЕКУЛЯРНЫЕ МЕХАНИЗМЫ ГЕНЕТИЧЕСКОЙ ИЗМЕНЧИВОСТИ ВИЧ-1, "Молекулярная биология"
Сосин, Д. В., & Churikov, N. A. (2017) · Molecular Biology · doi:10.7868/s0026898417030156 · Cited by 1
The scientific basis of pediatric HIV care
Smith, S., Melvin, A. J., Zeichner, S. L., McFarland, E. J., Palumbo, P. E., & Aldrovandi, G. M. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544781.003 · Cited by 4
Mórtola, E., Endo, Y., Risso, M. A., & Gimeno, E. J. (2000) · Veterinaria México OA · doi:10.21753/vmoa.31.4.23 · Cited by 1
Acquired immune deficiency syndrome caused by hyperimmunity
Chigira, M. (1996) · Medical Hypotheses · doi:10.1016/s0306-9877(96)90118-8 · Cited by 1
ChemInform Abstract: Rare Protein Turns: γ‐Turn, Helix—Turn—Helix, and cis‐Proline Mimics
Etzkorn, F. A., Travins, J. M., & Hart, S. A. (2000) · ChemInform · doi:10.1002/chin.200015250 · Cited by 1
Section Review: Biologicals & Immunologicals: Intracellular antibodies for HIV-1 gene therapy
Chen, S., Mhashikar, A. M., & Marasco, W. A. (1995) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.4.9.823 · Cited by 1
Host Genetic Variation and Susceptibility to Primate Lentiviruses
Johnson, W. E. (2007) · Future HIV Therapy · doi:10.2217/17469600.1.4.399 · Cited by 1
Immunomodulants in HIV infection
Bandera, A., Marchetti, G. C., & Gori, A. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.9.1115 · Cited by 1
Peptidyl‐prolylcis/transIsomerases
Fischer, G. S. (2008) · Protein Science Encyclopedia · doi:10.1002/9783527610754.sf16 · Cited by 1
Vuagniaux, G., Hamel, A., Crabbé, R., Porchet, H. C., & Dumont, J. (2011) · Methods and principles in medicinal chemistry · doi:10.1002/9783527635955.ch7 · Cited by 1
(1997) · Nature Structural Biology · doi:10.1038/nsb0297-85 · Cited by 1
Primate TRIM34 is a broadly-acting, TRIM5-dependent lentiviral restriction factorPreprint
Twentyman, J., Khalifeh, A., Felton, A., Emerman, M., & OhAinle, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.24.534139 · Cited by 1
The Expression of a Cytosolic Cyclophilin Promoter from Periwinkle in Transgenic Tobacco Plants
Droual, A.-M., Crèche, J., Andreu, F., Chénieux, J.-C., Rideau, M., & Hamdi, S. (2002) · Biologia Plantarum · doi:10.1023/a:1016249113274
Host Factors that Restrict Retrovirus Replication
Stenglein, M. D., Schumacher, A. J., LaRue, R. S., & Harris, R. S. (2009) · Springer eBooks · doi:10.1007/b135974_15
Identification of Cyclophilin gene family in soybean and characterization of GmCYP1
Mainali, H. R. (2013) · Scholarship@Western (Western University)
Sélection de peptides altérant le changement de cadre de lecture -1 programmé du VIH-1
Théberge-Julien, G. (2008) · doi:10.71781/26026
Madlala, P. (2011) · ResearchSpace (University of KwaZulu-Natal)
Retroviral Host Cell Factors: TRIM5, APOBEC3G and Cyclophilins
Sakuma, R., & Takeuchi, H. (2011) · InTech eBooks · doi:10.5772/21560
Rodríguez, G. S. (2008) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Misumi, S., Takamune, N., & Shoji, S. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-2323-5_14
MESSA A PUNTO DI TEST ALTERNATIVI PER LO SCREENING DI POTENZIALI INIBITORI DELLA PROTEASI DI HIV-1
Parolin, D. (2014) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/parolin-debora_phd2014-02-03
Studies on HIV-1 core assembly
Abdurahman, S. (2007) · Figshare
Filho, R. B., & Monteiro, C. M. (2008) · Americanae (AECID Library)
Role of the Capsid Helix 4-5 Loop in Equine Infectious Anemia Virus Infection
Bollman, B. (2013) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Characterisation of llama antibody fragments able to act as HIV-1 entry inhibitors
Quigley, A. F. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Section Reviews; Anti-infectives: Prolyl isomerases: Novel targets for anti-infective therapy?
Fliri, H. G. (1996) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.5.8.1003
Llewellyn, G. N. (2012) · Deep Blue (University of Michigan)
Multiple isoforms of cyclophilin A associated with human immunodeficiency virus type 1
Misumi, S. (2005) · Uirusu · doi:10.2222/jsv.55.273
Incorporation of cellular proteins into enveloped virus particles
Hammarstedt, M. (2006) · Figshare
Ruiz, A. J. (2010) · KU ScholarWorks (University of Kansas)
Inhibiting HIV-1 using RNA interference (RNAi) to target novel HIV dependency factors (HDFs)
Blondeel, M. D. (2010) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
The effect of alpha-HGA on HIV-1 replication
Youssefi, M. (2009) · Figshare
Cellular factors involved in HIV-1 replication
Rits, M. A. N. (2009) · UvA-DARE (University of Amsterdam)
Review Immunophilins: for the love of proteins
Barik, S. (2006)
DOCTORAT DE L'UNIVERSITE BORDEAUX 2
Benichou, M. S., & Araya, M. A. (2009)
Sorin, M., & Kalpana, G. V. (2016) · Einstein Journal of Biology and Medicine · doi:10.23861/ejbm2006227
Host Cell Factors in HIV-1 Replication Cycle
Boso, G. (2014) · University of Minnesota Digital Conservancy (University of Minnesota)
Heat Shock Protein-Based Therapeutic Strategies Against Human Immunodeficiency Virus
BRENNER, B. G., & Wainberg, M. A. (1999)
Tesi doctoral presentada per En/Na
Ironia, E. I. (2002)
Adachi, A., Yamamoto, Y., & Sone, S. (1996) · Uirusu · doi:10.2222/jsv.46.145
Anti-HIV chemotherapy targeted at host-cellular factors.
Baba, M. (1996) · Uirusu · doi:10.2222/jsv.46.155
The primate TRIMCyp fusion genes and mechanism of restricting retroviruses replication
Cao, G., Liu, F., Zhang, G., & Zheng, Y. (2013) · Zoological Research · doi:10.3724/sp.j.1141.2012.01099 · Cited by 3
Mechanisms of Apoptosis in Cancer: Regulatory Role of Caspases
Eßmann, F. (2000) · DepositOnce · doi:10.14279/depositonce-164
Schmid, F. X. (1999) · Protein · doi:10.1016/s1874-5989(99)80007-6
Formation of Specialized HSV-1 Egress Sites
Mingo, R. M. (2012) · doi:10.18130/v3ww0b
Novel Anti-Human Immunodeficiency Virus Compounds with Activity against Cyclophilin A: A Look Back
Tian, Y., Kawashita, N., Kameoka, M., & Takagi, T. (2016) · Journal of Prevention and Infection Control · doi:10.21767/2471-9668.100021
Cyclophilin A and HIV-1 Replication
Luban, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9610-6_74-1
Self-citationMartin, G. E. (2007) · Corpus Université Laval (Université Laval)
Greene, W. C., Peterlin, B. M., & Stremlau, M. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0695-2.00003-1
Shimizu, S., Kamata, M., Kittipongdaja, P., Chen, K. N., Kim, S., Pang, S., Boyer, J., Qin, F. X.-F., An, D. S., Chen, I. S. Y., et al. (2009)
(2014) · ASM Press eBooks · doi:10.1128/9781555815653.refs
(2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50209-0
Metadata
- Authors
- Franke, E. K., Yuan, H. E. H., & Luban, J.
- Affiliations
- Columbia University (US)
- ORCID
- Luban, Jeremy
- Venue
- Nature
- Published
- 1994-11
- Volume
- 372
- Issue
- 6504
- Pages
- 359-362
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2020597127
- Cited by
- 745
- References
- 28
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 9 · 2023: 16 · 2022: 7 · 2021: 13 · 2020: 16 · 2019: 12 · 2018: 13 · 2017: 10 · 2016: 18 · 2015: 19 · 2014: 28 · 2013: 25 · 2012: 32
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- cyclophilin A, HIV-1, Gag protein, viral assembly, peptidyl-prolyl isomerase, proline-rich region, host factors, HIV-1 replication
- MeSH terms
- Amino Acid Isomerases, Amino Acid Sequence, Base Sequence, Carrier Proteins, Cell Line, HeLa Cells, Humans, Molecular Sequence Data, Oligodeoxyribonucleotides, Transfection, Virion, Virus Replication, Simian Immunodeficiency Virus, HIV-1, Gene Products, gag, Mutagenesis, Peptidylprolyl Isomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.